HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient.

Abstract
A case of early-onset sclerolimbal ectasia following low-dose topical mitomycin C application during uveitic glaucoma surgery is reported. Intraoperative and postoperative clinical courses were consistent with sclerolimbal ectasia. Adjunctive utilization of intraoperative low-dose 0.02% mitomycin C for the management of chronic uveitic glaucoma patients who are under concomitant systemic immunosuppressive regimen may enhance the risk of subacute postoperative sclerolimbal ectasia. Mitomycin C concentrations < 0.02%, decreased scleral exposure time, and a strict informed consent policy are strongly recommended in this subset of uveitic patients.
AuthorsA Pirouzian, H O'Halloran, C Scher, Y Jockin
JournalOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (Ophthalmologica) Vol. 220 Issue 6 Pg. 406-8 ( 2006) ISSN: 0030-3755 [Print] Switzerland
PMID17095889 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2006 S. Karger AG, Basel.
Chemical References
  • Alkylating Agents
  • Mitomycin
Topics
  • Adolescent
  • Alkylating Agents (administration & dosage, adverse effects)
  • Combined Modality Therapy
  • Corneal Diseases (chemically induced)
  • Dilatation, Pathologic (chemically induced)
  • Glaucoma, Open-Angle (drug therapy, surgery, therapy)
  • Humans
  • Intraocular Pressure
  • Male
  • Mitomycin (administration & dosage, adverse effects)
  • Scleral Diseases (chemically induced)
  • Trabeculectomy
  • Uveitis, Anterior (drug therapy, surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: